Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15383562 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Autologous Dendritic Cell Therapy for Type 1 Diabetes Suppression: A Safety Study
Condition: Diabetes Mellitus, Insulin-Dependent
Interventions: Biological: Diabetes-suppressive dendritic cell vaccine;   Biological: control dendritic cells

Indicates status has not been verified in more than two years